Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations

Mauro Longoni, Silvia Moncini, Mariangela Cisternino, Ilaria M. Morella, Serena Ferraiuolo, Silvia Russo, Savina Mannarino, Valeria Brazzelli, Paola Coi, Renata Zippel, Marco Venturin, Paola Riva

Research output: Contribution to journalArticle

Abstract

Noonan syndrome is a genetic condition characterized by congenital heart defects, short stature, and characteristic facial features. Familial or de novo mutations in PTPN11, RAF1, SOS1, KRAS, and NRAS are responsible for 60-75% of the cases, thus, additional genes are expected to be involved in the pathogenesis. In addition, the genotype-phenotype correlation has been hindered by the highly variable expressivity of the disease. For all these reasons, expanding the genotyped and clinically evaluated case numbers will benefit the clinical community. A mutation analysis has been performed on RAF1, SOS1, and GRB2, in 24 patients previously found to be negative for PTPN11 and KRAS mutations. We identified four mutations in SOS1 and one in RAF1, while no GRB2 variants have been found. Interestingly, the RAF1 mutation was present in a patient also carrying a newly identified p.R497Q familial SOS1 mutation, segregating with a typical Noonan Syndrome SOS1 cutaneous phenotype. Functional analysis demonstrated that the R497Q SOS1 mutation leads to Jnk activation, but has no effect on the Ras effector Erk1. We propose that this variant might contribute to the onset of the peculiar ectodermal traits displayed by the propositus amidst the more classical Noonan syndrome presentation. To our knowledge, this is the first reported case of a patient harboring mutations in two genes, with an involvement of both Ras and Rac1 pathways, indicating that SOS1 may have a role of modifier gene that might contribute the variable expressivity of the disease, evidencing a genotype-phenotype correlation in the family.

Original languageEnglish
Pages (from-to)2176-2184
Number of pages9
JournalAmerican Journal of Medical Genetics, Part A
Volume152
Issue number9
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Noonan Syndrome
Mutation
Genetic Association Studies
Modifier Genes
Congenital Heart Defects
Genes
Phenotype
Skin

Keywords

  • Genotype-phenotype correlation
  • GRB2
  • Jnk activation
  • Mutational analysis
  • Noonan syndrome
  • RAF1
  • SOS1

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations. / Longoni, Mauro; Moncini, Silvia; Cisternino, Mariangela; Morella, Ilaria M.; Ferraiuolo, Serena; Russo, Silvia; Mannarino, Savina; Brazzelli, Valeria; Coi, Paola; Zippel, Renata; Venturin, Marco; Riva, Paola.

In: American Journal of Medical Genetics, Part A, Vol. 152, No. 9, 09.2010, p. 2176-2184.

Research output: Contribution to journalArticle

Longoni, M, Moncini, S, Cisternino, M, Morella, IM, Ferraiuolo, S, Russo, S, Mannarino, S, Brazzelli, V, Coi, P, Zippel, R, Venturin, M & Riva, P 2010, 'Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations', American Journal of Medical Genetics, Part A, vol. 152, no. 9, pp. 2176-2184. https://doi.org/10.1002/ajmg.a.33564
Longoni, Mauro ; Moncini, Silvia ; Cisternino, Mariangela ; Morella, Ilaria M. ; Ferraiuolo, Serena ; Russo, Silvia ; Mannarino, Savina ; Brazzelli, Valeria ; Coi, Paola ; Zippel, Renata ; Venturin, Marco ; Riva, Paola. / Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations. In: American Journal of Medical Genetics, Part A. 2010 ; Vol. 152, No. 9. pp. 2176-2184.
@article{d606890b7b674d78bc27eccb306037f8,
title = "Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations",
abstract = "Noonan syndrome is a genetic condition characterized by congenital heart defects, short stature, and characteristic facial features. Familial or de novo mutations in PTPN11, RAF1, SOS1, KRAS, and NRAS are responsible for 60-75{\%} of the cases, thus, additional genes are expected to be involved in the pathogenesis. In addition, the genotype-phenotype correlation has been hindered by the highly variable expressivity of the disease. For all these reasons, expanding the genotyped and clinically evaluated case numbers will benefit the clinical community. A mutation analysis has been performed on RAF1, SOS1, and GRB2, in 24 patients previously found to be negative for PTPN11 and KRAS mutations. We identified four mutations in SOS1 and one in RAF1, while no GRB2 variants have been found. Interestingly, the RAF1 mutation was present in a patient also carrying a newly identified p.R497Q familial SOS1 mutation, segregating with a typical Noonan Syndrome SOS1 cutaneous phenotype. Functional analysis demonstrated that the R497Q SOS1 mutation leads to Jnk activation, but has no effect on the Ras effector Erk1. We propose that this variant might contribute to the onset of the peculiar ectodermal traits displayed by the propositus amidst the more classical Noonan syndrome presentation. To our knowledge, this is the first reported case of a patient harboring mutations in two genes, with an involvement of both Ras and Rac1 pathways, indicating that SOS1 may have a role of modifier gene that might contribute the variable expressivity of the disease, evidencing a genotype-phenotype correlation in the family.",
keywords = "Genotype-phenotype correlation, GRB2, Jnk activation, Mutational analysis, Noonan syndrome, RAF1, SOS1",
author = "Mauro Longoni and Silvia Moncini and Mariangela Cisternino and Morella, {Ilaria M.} and Serena Ferraiuolo and Silvia Russo and Savina Mannarino and Valeria Brazzelli and Paola Coi and Renata Zippel and Marco Venturin and Paola Riva",
year = "2010",
month = "9",
doi = "10.1002/ajmg.a.33564",
language = "English",
volume = "152",
pages = "2176--2184",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations

AU - Longoni, Mauro

AU - Moncini, Silvia

AU - Cisternino, Mariangela

AU - Morella, Ilaria M.

AU - Ferraiuolo, Serena

AU - Russo, Silvia

AU - Mannarino, Savina

AU - Brazzelli, Valeria

AU - Coi, Paola

AU - Zippel, Renata

AU - Venturin, Marco

AU - Riva, Paola

PY - 2010/9

Y1 - 2010/9

N2 - Noonan syndrome is a genetic condition characterized by congenital heart defects, short stature, and characteristic facial features. Familial or de novo mutations in PTPN11, RAF1, SOS1, KRAS, and NRAS are responsible for 60-75% of the cases, thus, additional genes are expected to be involved in the pathogenesis. In addition, the genotype-phenotype correlation has been hindered by the highly variable expressivity of the disease. For all these reasons, expanding the genotyped and clinically evaluated case numbers will benefit the clinical community. A mutation analysis has been performed on RAF1, SOS1, and GRB2, in 24 patients previously found to be negative for PTPN11 and KRAS mutations. We identified four mutations in SOS1 and one in RAF1, while no GRB2 variants have been found. Interestingly, the RAF1 mutation was present in a patient also carrying a newly identified p.R497Q familial SOS1 mutation, segregating with a typical Noonan Syndrome SOS1 cutaneous phenotype. Functional analysis demonstrated that the R497Q SOS1 mutation leads to Jnk activation, but has no effect on the Ras effector Erk1. We propose that this variant might contribute to the onset of the peculiar ectodermal traits displayed by the propositus amidst the more classical Noonan syndrome presentation. To our knowledge, this is the first reported case of a patient harboring mutations in two genes, with an involvement of both Ras and Rac1 pathways, indicating that SOS1 may have a role of modifier gene that might contribute the variable expressivity of the disease, evidencing a genotype-phenotype correlation in the family.

AB - Noonan syndrome is a genetic condition characterized by congenital heart defects, short stature, and characteristic facial features. Familial or de novo mutations in PTPN11, RAF1, SOS1, KRAS, and NRAS are responsible for 60-75% of the cases, thus, additional genes are expected to be involved in the pathogenesis. In addition, the genotype-phenotype correlation has been hindered by the highly variable expressivity of the disease. For all these reasons, expanding the genotyped and clinically evaluated case numbers will benefit the clinical community. A mutation analysis has been performed on RAF1, SOS1, and GRB2, in 24 patients previously found to be negative for PTPN11 and KRAS mutations. We identified four mutations in SOS1 and one in RAF1, while no GRB2 variants have been found. Interestingly, the RAF1 mutation was present in a patient also carrying a newly identified p.R497Q familial SOS1 mutation, segregating with a typical Noonan Syndrome SOS1 cutaneous phenotype. Functional analysis demonstrated that the R497Q SOS1 mutation leads to Jnk activation, but has no effect on the Ras effector Erk1. We propose that this variant might contribute to the onset of the peculiar ectodermal traits displayed by the propositus amidst the more classical Noonan syndrome presentation. To our knowledge, this is the first reported case of a patient harboring mutations in two genes, with an involvement of both Ras and Rac1 pathways, indicating that SOS1 may have a role of modifier gene that might contribute the variable expressivity of the disease, evidencing a genotype-phenotype correlation in the family.

KW - Genotype-phenotype correlation

KW - GRB2

KW - Jnk activation

KW - Mutational analysis

KW - Noonan syndrome

KW - RAF1

KW - SOS1

UR - http://www.scopus.com/inward/record.url?scp=77956099847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956099847&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.33564

DO - 10.1002/ajmg.a.33564

M3 - Article

C2 - 20683980

AN - SCOPUS:77956099847

VL - 152

SP - 2176

EP - 2184

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -